Gallium compounds |
Gallium nitrate: treatment of hypercalcemia of malignancy |
Growth inhibition of several recalcitrant bacterial pathogens (including clinical isolates) such as: Gram (-) Pseudomonas aeruginosa y A. baumanii and Gram (+) like Mycobacterium tuberculosis
|
Effective against syphilis (Treponema cuniculi) in rabbits and trypanosomiasis in mice, guinea pigs, and monkeys Acute and chronic mice infections of P. aeruginosa A. baumannii infections in caterpillar and mice |
Levaditi et al. (1931), Olakanmi et al. (2000), Kaneko et al. (2007), DeLeon et al. (2009), Antunes et al. (2012), de Leseleuc et al. (2012)
|
5-Florouracil |
Anticancer drug Treatment of actinic keratosis and Bowen's disease |
Growth inhibition of Gram (+) and (-) bacterial species Inhibition of biofilm formation Repression of QS in P. aeruginosa
|
Successful in clinical trials in humans, as external coating of central venous catheters |
Hussain et al. (1992), Ueda et al. (2009), Walz et al. (2010)
|
Ciclopirox |
Antifungal |
Bacteriostatic and bactericide activity, depending on concentration used, in laboratory and clinical isolates |
Not yet tested |
Carlson-Banning et al. (2013)
|
5-fluorocytosine |
Antifungal |
Inhibition of virulence factor production by P. aeruginosa
|
Suppresses P. aeruginosa pathogenicity in a mouse model of lung infection |
Imperi et al. (2013a) |
Azithromycin |
Antibiotic |
Inhibition of QS systems of P. aeruginosa
|
Clinical evidence and clinical trials demonstrate efficacy in the treatment of chronic pulmonary infections of P. aeruginosa
|
Imperi et al. (2014) |
Niclosamide |
Antihelmintic |
Inhibition of QS systems of P. aeruginosa
|
Reduction of P. aeruginosa pathogenicity in an insect model |
Imperi et al. (2013b) |
Diflunisal |
Non-steroidal anti-inflammatory |
Potent virulence inhibitor for the USA300 strain of methicillin-resistant Staphylococcus aureus (MRSA) |
Not yet tested |
Khodaverdian et al. (2013) |
Statins |
Lower plasma cholesterol levels |
Reduction of virulence factor production of P. aeruginosa Broad spectrum antibacterial effects |
Inhibition of S. pneumoniae attachment to lung and vascular tissue |
Rosch et al. (2010) |
Pentetic acid |
Preparation of radiopharmaceuticals treatment of iron-storage disease and poisoning from heavy metals |
Reduction of virulence factor production of P. aeruginosa
|
Effective to alleviate mice airway infections |
Gi et al. (2014) |
Terfenadine |
Antihistamine |
Inhibit growth of several pathogenic bacteria, including S. aureus and M. tuberculosis
|
Not yet tested |
Perlmutter et al. (2014) |
Zafirlukast |
Treatment of asthma |
Antimycobacterial |
Not yet tested |
Pinault et al. (2013) |